Sun BioPharma, Inc. Stock Price - SNBP

Best deals to access real time data!
Real-Time Alerts for Volume Breakouts, Highs and Lows for OTC Markets and OTCBB
Monthly Subscription
for only
$50.99
SMALL CAP PRO
Monthly Subscription
for only
$44.59
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
$60.99
VAT not included
Company Name Stock Ticker Symbol Market Type ISIN
Sun Biopharma, Inc. (QB) SNBP Other OTC Common Stock
  Price Change Change Percent Stock Price High Price Low Price Open Price Close Price Last Traded
  +0 +0% 12 12 12 12 12 15:43:22
Bid Price Ask Price Spread Spread % News
10.55 12.25 1.7 13.88% - -
Stock Trades Traded Volume VWAP Dollar Volume Average Volume 52 Week Range
3 300 $ 12.0000 $ 3.6k 308 1.00 - 15.00
Last Trade Time Type Quantity Stock Price Currency
15:43:22 100 $12.00 USD

Sun Biopharma, Inc. (QB) Financials

Market Cap Shares in Issue Profit/Loss Earnings Per Share (EPS) PE Ratio Float
$ 44.05M 3.67M $ -4.93M - -8.94 -
Short Interest Dividends Per Share Dividend Yield Ex-Div Date Insider B/S Insider % Owned
- $ - 0.00% - -

more financials information »

Sun Biopharma, Inc. (QB) News

Date Time Source News Article
12/04/201708:36Edgar (US Regulatory)Current Report Filing (8-k)
12/04/201708:35Edgar (US Regulatory)Securities Registration Statement (s-1/a)
11/15/201707:09Edgar (US Regulatory)Current Report Filing (8-k)
11/14/201708:34Edgar (US Regulatory)Quarterly Report (10-q)
11/14/201708:34Edgar (US Regulatory)Current Report Filing (8-k)

Latest SNBP Messages

{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}}

Loading Messages....


No posts yet, be the first! No {{symbol}} Message Board. Create One! See More Posts on {{symbol}} Message Board See More Message Board Posts

Historical SNBP Price Data

Period † Open High Low VWAP Min Vol Max Vol Avg. Daily Vol [m] Change %
1 Week141410.9911.14340500206-2-14.29%
1 Month11.7514.98110.456602k3600.252.13%
3 Months1515110.940202k321-3-20.00%
6 Months1515110.940202k321-3-20.00%
1 Year1515110.940202k321-3-20.00%
3 Years1515110.940202k321-3-20.00%
5 Years1515110.940202k321-3-20.00%

Sun Biopharma, Inc. (QB) Description

Sun BioPharma Inc. is a clinical-stage bio-pharmaceutical company developing disruptive therapeutics for significant unmet medical needs. The Company's initial programs are aimed at diseases of the pancreas, including pancreatic cancer and pancreatitis. The Company has completed enrollment in its first-in-human Phase 1a clinical safety trial of SBP-101, in the treatment of previously treated pancreatic cancer patients. The trial established a safe and well tolerated dose. The Company anticipates initiation of patient enrollment in its next clinical trial in the first quarter of 2018 which will be a Phase 1a/1b study of the safety and efficacy of SBP-101 administered in combination with gemcitabine and nab-paclitaxel. Sun BioPharma has scientific collaborations with pancreatic disease experts the Mayo Clinic Scottsdale and Cedars Sinai Medical Center in the US, the University of Miami, the Austin Health Cancer Trials Centre and the Ashford Cancer Centre in Australia. SBP-101 is a novel small-molecule synthetic polyamine compound designed to exert therapeutic effects in a mechanism of action specific to the pancreas. SBP-101 has been shown to be highly effective in several human pancreatic cancer models, demonstrating superior activity to existing chemotherapy agents. Combination potential has also been shown for pancreatic cancer. SBP-101 is expected to hold an edge over current pancreatic cancer therapies, as it specifically targets the exocrine pancreas.
Your Recent History
LSE
GKP
Gulf Keyst..
LSE
QPP
Quindell
FTSE
UKX
FTSE 100
LSE
IOF
Iofina
FX
GBPUSD
UK Sterlin..
Stocks you've viewed will appear in this box, letting you easily return to quotes you've seen previously.

Register now to create your own custom streaming stock watchlist.

By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions

P:31 V: D:20171216 08:52:01